Massard C - Search Results

1

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

Loriot Y, Bianchini D, Ileana E, Sandhu S, Patrikidou A, Pezaro C, Albiges L, Attard G, Fizazi K, De Bono JS, Massard C. Loriot Y, et al. Among authors: massard c. Ann Oncol. 2013 Jul;24(7):1807-1812. doi: 10.1093/annonc/mdt136. Epub 2013 Apr 10. Ann Oncol. 2013. PMID: 23576708 Free article.

2

Risk factors for brain relapse in patients with metastatic breast cancer.

Slimane K, Andre F, Delaloge S, Dunant A, Perez A, Grenier J, Massard C, Spielmann M. Slimane K, et al. Among authors: massard c. Ann Oncol. 2004 Nov;15(11):1640-4. doi: 10.1093/annonc/mdh432. Ann Oncol. 2004. PMID: 15520065 Free article.

3

Tumour stem cell-targeted treatment: elimination or differentiation.

Massard C, Deutsch E, Soria JC. Massard C, et al. Ann Oncol. 2006 Nov;17(11):1620-4. doi: 10.1093/annonc/mdl074. Epub 2006 May 3. Ann Oncol. 2006. PMID: 16600978 Free article. Review.

4

[Locally advanced prostate cancer: definition, prognosis and treatment].

Plantade A, Massard C, de Crevoisier R, Fizazi K. Plantade A, et al. Among authors: massard c. Bull Cancer. 2007 Jul;94(7 Suppl):F50-61. Bull Cancer. 2007. PMID: 17845994 Review. French.

5

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

Massard C, Voigt JJ, Laplanche A, Culine S, Lortholary A, Bugat R, Theodore C, Priou F, Kaminsky MC, Lesimple T, Pivot X, Coudert B, Douillard JY, Merrouche Y, Fizazi K. Massard C, et al. Br J Cancer. 2007 Oct 8;97(7):857-61. doi: 10.1038/sj.bjc.6603942. Epub 2007 Sep 18. Br J Cancer. 2007. PMID: 17876336 Free PMC article. Clinical Trial.

6

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy.

Italiano A, Massard C, Bahleda R, Vataire AL, Deutsch E, Magné N, Pignon JP, Vassal G, Armand JP, Soria JC. Italiano A, et al. Among authors: massard c. Ann Oncol. 2008 Apr;19(4):787-92. doi: 10.1093/annonc/mdm548. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042834 Free article. Review.

7

The postchemotherapy PSA surge syndrome.

Thuret R, Massard C, Gross-Goupil M, Escudier B, Di Palma M, Bossi A, de Crevoisier R, Chauchereau A, Fizazi K. Thuret R, et al. Among authors: massard c. Ann Oncol. 2008 Jul;19(7):1308-1311. doi: 10.1093/annonc/mdn062. Epub 2008 Mar 19. Ann Oncol. 2008. PMID: 18356135 Free article.

8

Carcinomas of an unknown primary site: a curable disease?

Levy A, Massard C, Gross-Goupil M, Fizazi K. Levy A, et al. Among authors: massard c. Ann Oncol. 2008 Sep;19(9):1657-8. doi: 10.1093/annonc/mdn430. Epub 2008 Jul 22. Ann Oncol. 2008. PMID: 18647966 Free article. No abstract available.

9

Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features.

Loriot Y, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Bossi A, Fizazi K. Loriot Y, et al. Among authors: massard c. Ann Oncol. 2009 Apr;20(4):703-8. doi: 10.1093/annonc/mdn694. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179557 Free article.

10

The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancer.

Massard C, Chauchereau A, Fizazi K. Massard C, et al. Ann Oncol. 2009 Feb;20(2):197-9. doi: 10.1093/annonc/mdp017. Ann Oncol. 2009. PMID: 19211498 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters